Market Cap (In USD)
1.92 Million
Revenue (In USD)
1.4 Million
Net Income (In USD)
-468.36 Thousand
Avg. Volume
7823.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.033-0.35
- PE
- -
- EPS
- -
- Beta Value
- -0.672
- ISIN
- US90350R1077
- CUSIP
- 90350R107
- CIK
- 856984
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Troy James Grogan
- Employee Count
- -
- Website
- https://www.usaqcorp.com
- Ipo Date
- 2013-05-22
- Details
- QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It also develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. In addition, the company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. The company was incorporated in 1983 and is based in West Palm Beach, Florida.
More Stocks
-
UNLRF
-
7716ITI
7716
-
WSR
-
0323
-
AAGRY
-
1997
-
DBCORPD. B. Corp Limited
DBCORP
-
605268